Human Genome Research Project
Research arm of the Western Sydney Genetics Program
Evaluation of Innovative Genetic Therapies
Our research over the past 5 years has focussed on studying the natural history of the musculoskeletal effects of Lysosomal Storage Disorders in Children and Adults. We are evaluating enzyme replacement therapies (ERT) for MPS VI, MPS I, Fabry and Pompe disease and Bisphosphonate therapies in Mucolipidosis (see Centre for Innovative Genetic Therapies).
This document was reviewed on Monday, 27 February 2006
|